Alembic Pharma gets tentative USFDA nod for generic version of Dabigatran Etexilate capsules

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug (RLD) product Pradaxa Capsules, 75 mg, 110 mg, and 150 mg of Boehringer Ingelheim Pharmaceuticals, Inc (Boehringer)

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/elhQNWy
via IFTTT